Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Christina Aquilante

Concepts (357)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacogenetics
29
2024
172
6.290
 Why?
Pharmacogenomic Testing
14
2024
61
4.270
 Why?
Thiazolidinediones
8
2016
137
2.730
 Why?
Aryl Hydrocarbon Hydroxylases
10
2014
48
2.380
 Why?
Heart Transplantation
9
2024
721
2.290
 Why?
Polymorphism, Genetic
17
2019
637
2.150
 Why?
Organ Transplantation
3
2024
228
1.790
 Why?
Cytochrome P-450 CYP3A
8
2024
88
1.670
 Why?
Precision Medicine
10
2024
387
1.600
 Why?
Genotype
20
2025
1833
1.540
 Why?
Polymorphism, Single Nucleotide
11
2024
2060
1.490
 Why?
Tacrolimus
3
2024
193
1.480
 Why?
Cytochrome P-450 CYP2C19
6
2024
23
1.390
 Why?
Health Personnel
4
2021
653
1.360
 Why?
Hypoglycemic Agents
11
2020
1221
1.320
 Why?
Transplant Recipients
6
2024
163
1.280
 Why?
Decision Support Systems, Clinical
2
2024
205
1.250
 Why?
Graft Rejection
3
2024
598
1.120
 Why?
Blood Pressure
8
2020
1736
1.110
 Why?
Metabolic Syndrome
4
2016
340
1.090
 Why?
Cytochrome P-450 CYP2D6
4
2022
28
1.030
 Why?
Pharmacists
3
2022
246
0.930
 Why?
Immunosuppressive Agents
6
2024
858
0.920
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2024
430
0.810
 Why?
Cost-Benefit Analysis
3
2024
569
0.790
 Why?
Gemfibrozil
2
2013
11
0.770
 Why?
Sulfonylurea Compounds
3
2018
46
0.740
 Why?
Hepatocyte Nuclear Factor 1-alpha
1
2021
16
0.740
 Why?
Leukopenia
1
2021
28
0.730
 Why?
Adiponectin
2
2016
235
0.730
 Why?
Hypolipidemic Agents
2
2013
92
0.720
 Why?
Warfarin
4
2024
147
0.720
 Why?
Mycophenolic Acid
1
2021
110
0.690
 Why?
Organic Anion Transporters
2
2011
16
0.680
 Why?
Desogestrel
5
2021
45
0.680
 Why?
Biological Specimen Banks
2
2024
97
0.680
 Why?
Platelet Aggregation Inhibitors
1
2024
443
0.680
 Why?
Humans
81
2025
129625
0.650
 Why?
Hypertension
3
2020
1243
0.640
 Why?
Adult
43
2024
35599
0.620
 Why?
Middle Aged
41
2024
31136
0.620
 Why?
Prescription Drugs
2
2020
112
0.620
 Why?
Cytochrome P-450 CYP2C8
7
2014
15
0.610
 Why?
Cardiologists
1
2018
46
0.600
 Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2021
46
0.570
 Why?
Physicians
3
2021
866
0.570
 Why?
HIV Protease Inhibitors
4
2016
68
0.560
 Why?
Academic Medical Centers
1
2020
475
0.540
 Why?
Ritonavir
4
2012
73
0.540
 Why?
Male
48
2024
63670
0.540
 Why?
Female
52
2024
68734
0.540
 Why?
Heart Failure
4
2017
2133
0.520
 Why?
Polypharmacy
1
2017
84
0.510
 Why?
Lectins
1
2016
48
0.500
 Why?
Nonprescription Drugs
1
2016
66
0.490
 Why?
Attitude of Health Personnel
2
2020
1098
0.490
 Why?
Antiviral Agents
1
2021
715
0.480
 Why?
Dihydrouracil Dehydrogenase (NADP)
2
2025
2
0.470
 Why?
Dihydropyrimidine Dehydrogenase Deficiency
2
2025
2
0.470
 Why?
Medicare
1
2020
708
0.460
 Why?
Cytochrome P-450 Enzyme System
2
2006
151
0.460
 Why?
Contraceptive Agents, Female
3
2020
78
0.450
 Why?
Death, Sudden, Cardiac
3
2021
179
0.450
 Why?
Pediatrics
2
2021
1056
0.430
 Why?
Blood Pressure Determination
1
2014
148
0.420
 Why?
Chemokine CXCL5
3
2012
11
0.410
 Why?
Arrhythmias, Cardiac
3
2021
320
0.410
 Why?
Heptanoic Acids
1
2013
64
0.400
 Why?
Anticoagulants
3
2024
637
0.390
 Why?
Pyrazines
1
2013
87
0.380
 Why?
Retrospective Studies
15
2024
14522
0.380
 Why?
Resistin
2
2010
11
0.380
 Why?
Pharmaceutical Preparations
3
2009
171
0.380
 Why?
Pyrroles
1
2013
202
0.380
 Why?
Pravastatin
1
2011
40
0.380
 Why?
Triazoles
1
2013
148
0.370
 Why?
Diabetes Mellitus, Type 2
5
2020
2442
0.370
 Why?
Health Knowledge, Attitudes, Practice
4
2021
1280
0.370
 Why?
Dobutamine
3
2008
37
0.360
 Why?
Cross-Sectional Studies
8
2020
5075
0.360
 Why?
Aged
19
2024
22061
0.340
 Why?
Managed Care Programs
2
2022
133
0.340
 Why?
Antidepressive Agents
2
2022
229
0.330
 Why?
Mixed Function Oxygenases
2
2008
41
0.320
 Why?
DNA
1
2016
1404
0.320
 Why?
Drug Interactions
5
2017
395
0.310
 Why?
Chromatography, Liquid
1
2010
423
0.300
 Why?
Polymerase Chain Reaction
3
2006
1035
0.300
 Why?
Drug Prescriptions
4
2021
248
0.290
 Why?
Health
1
2008
75
0.290
 Why?
International Normalized Ratio
2
2024
46
0.290
 Why?
Sulfonamides
1
2011
497
0.290
 Why?
Young Adult
13
2021
12455
0.290
 Why?
Cytokines
1
2016
2021
0.290
 Why?
Time Factors
8
2020
6555
0.280
 Why?
Chemokine CCL2
1
2008
117
0.280
 Why?
Antimetabolites, Antineoplastic
2
2025
91
0.280
 Why?
Drug Implants
4
2021
82
0.280
 Why?
Mass Spectrometry
1
2010
714
0.270
 Why?
Receptors, Adrenergic, beta
1
2008
127
0.270
 Why?
Fluorouracil
2
2025
197
0.270
 Why?
Blood Glucose
3
2016
2100
0.270
 Why?
Matrix Metalloproteinase 8
1
2006
8
0.270
 Why?
Haplotypes
5
2013
475
0.270
 Why?
Heart Rate
3
2008
802
0.270
 Why?
Sequence Analysis, DNA
4
2012
778
0.260
 Why?
Prospective Studies
7
2024
7135
0.260
 Why?
United States
11
2024
13871
0.250
 Why?
Vitamin K Epoxide Reductases
3
2020
12
0.250
 Why?
Metoprolol
1
2006
39
0.250
 Why?
Electronic Health Records
3
2024
973
0.250
 Why?
Blood Coagulation Factors
1
2006
53
0.250
 Why?
Clinical Laboratory Techniques
1
2006
94
0.250
 Why?
Autonomic Nervous System
1
2006
75
0.250
 Why?
Models, Biological
1
2013
1724
0.240
 Why?
Clinical Protocols
2
2017
254
0.240
 Why?
Administration, Oral
4
2016
787
0.240
 Why?
Capecitabine
1
2025
45
0.240
 Why?
Genetic Variation
3
2019
939
0.230
 Why?
Echocardiography
1
2008
634
0.230
 Why?
Echocardiography, Stress
1
2004
20
0.230
 Why?
Cross-Over Studies
3
2013
520
0.230
 Why?
Polymorphism, Restriction Fragment Length
1
2004
69
0.220
 Why?
Adverse Drug Reaction Reporting Systems
1
2024
74
0.220
 Why?
Follow-Up Studies
5
2024
4894
0.220
 Why?
Carrier Proteins
1
2008
745
0.220
 Why?
Adrenergic beta-Antagonists
1
2006
321
0.220
 Why?
United States Food and Drug Administration
1
2024
205
0.210
 Why?
Cohort Studies
7
2021
5426
0.210
 Why?
Biotransformation
2
2013
67
0.210
 Why?
Cytochrome P-450 CYP2C9
4
2019
20
0.210
 Why?
Alleles
6
2012
847
0.210
 Why?
Metformin
1
2007
318
0.210
 Why?
Waist Circumference
2
2016
138
0.200
 Why?
Gene Frequency
4
2013
502
0.200
 Why?
Antimalarials
2
2013
30
0.190
 Why?
Clinical Trials as Topic
1
2006
1005
0.190
 Why?
Aged, 80 and over
5
2024
7052
0.190
 Why?
Dose-Response Relationship, Drug
4
2024
2011
0.190
 Why?
Drug Dosage Calculations
1
2020
22
0.180
 Why?
Calcineurin Inhibitors
1
2021
68
0.170
 Why?
Pharmacogenomic Variants
2
2021
35
0.170
 Why?
Antibiotics, Antineoplastic
1
2021
123
0.170
 Why?
Egypt
1
2020
10
0.170
 Why?
Cytomegalovirus
1
2021
154
0.170
 Why?
Atazanavir Sulfate
3
2016
41
0.170
 Why?
Area Under Curve
2
2013
304
0.170
 Why?
Diabetes Mellitus
2
2024
1001
0.160
 Why?
No-Show Patients
1
2019
1
0.160
 Why?
Menstruation Disturbances
1
2019
12
0.160
 Why?
Brain Chemistry
1
2000
118
0.160
 Why?
Colorado
3
2024
4404
0.160
 Why?
Cardiovascular Diseases
3
2024
2006
0.160
 Why?
Lipids
2
2016
627
0.160
 Why?
Cytochrome P450 Family 3
1
2019
3
0.160
 Why?
Hemodynamics
1
2004
1090
0.160
 Why?
Smoking
1
2006
1500
0.160
 Why?
Blood Pressure Monitoring, Ambulatory
1
2020
83
0.160
 Why?
Oligopeptides
2
2012
258
0.150
 Why?
Body Weight
2
2016
940
0.150
 Why?
Morphine
1
2000
138
0.150
 Why?
Patients
1
2020
169
0.150
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2013
338
0.150
 Why?
Double-Blind Method
2
2016
1875
0.150
 Why?
Child Health Services
1
2020
184
0.150
 Why?
Sitagliptin Phosphate
2
2021
32
0.150
 Why?
Progesterone
1
2019
245
0.150
 Why?
Ventricular Dysfunction
1
2018
15
0.150
 Why?
Treatment Outcome
7
2024
10219
0.140
 Why?
Bariatric Surgery
1
2021
196
0.140
 Why?
Body Mass Index
3
2019
2274
0.140
 Why?
Psychiatry
1
2020
179
0.140
 Why?
Apyrase
1
2017
16
0.140
 Why?
Pyridines
2
2012
478
0.140
 Why?
Organophosphonates
2
2008
91
0.140
 Why?
Healthy Volunteers
2
2019
201
0.140
 Why?
DNA Primers
3
2006
511
0.130
 Why?
Pyrophosphatases
1
2016
22
0.130
 Why?
Chronic Disease
2
2017
1720
0.130
 Why?
Circadian Rhythm
1
2020
413
0.130
 Why?
Anti-HIV Agents
2
2016
757
0.130
 Why?
Depression
2
2022
1317
0.130
 Why?
Cardiology
1
2018
266
0.130
 Why?
GPI-Linked Proteins
1
2016
68
0.120
 Why?
Gene Expression Regulation, Enzymologic
1
2017
285
0.120
 Why?
Patient Care
1
2016
108
0.120
 Why?
Ribavirin
1
2016
91
0.120
 Why?
Adenine
2
2008
258
0.120
 Why?
Students, Pharmacy
1
2016
96
0.120
 Why?
Metabolic Clearance Rate
2
2013
117
0.120
 Why?
HIV Infections
4
2016
2730
0.120
 Why?
Therapeutics
1
2015
14
0.120
 Why?
Education, Pharmacy
1
2016
119
0.120
 Why?
Voriconazole
1
2015
20
0.120
 Why?
beta-Cyclodextrins
1
2015
27
0.120
 Why?
Delivery of Health Care
1
2022
898
0.120
 Why?
Renal Replacement Therapy
1
2015
87
0.110
 Why?
Patient Education as Topic
1
2019
737
0.110
 Why?
Surgical Procedures, Operative
1
2017
244
0.110
 Why?
Diltiazem
1
2014
28
0.110
 Why?
Antigens, CD
1
2017
487
0.110
 Why?
Antifungal Agents
1
2015
130
0.110
 Why?
Phenotype
3
2024
3075
0.110
 Why?
Chromosomes, Human, Pair 10
1
2013
18
0.110
 Why?
Reoperation
1
2016
541
0.110
 Why?
Adolescent
6
2021
20412
0.110
 Why?
Kidney Transplantation
1
2019
670
0.100
 Why?
Cardiomyopathies
1
2017
340
0.100
 Why?
Venous Thromboembolism
1
2017
287
0.100
 Why?
Half-Life
1
2013
162
0.100
 Why?
Sirolimus
1
2014
270
0.100
 Why?
Tissue Distribution
2
2014
315
0.100
 Why?
Medication Adherence
1
2017
558
0.100
 Why?
Liver Transplantation
1
2019
833
0.100
 Why?
Practice Patterns, Physicians'
1
2020
1271
0.090
 Why?
Surveys and Questionnaires
2
2024
5415
0.090
 Why?
Darunavir
1
2011
18
0.090
 Why?
Lung Transplantation
1
2014
289
0.090
 Why?
Self Care
1
2014
363
0.090
 Why?
Genetic Association Studies
1
2013
362
0.090
 Why?
Acquired Immunodeficiency Syndrome
1
2012
228
0.090
 Why?
Reverse Transcriptase Inhibitors
2
2008
83
0.090
 Why?
Insulin Resistance
2
2010
1167
0.080
 Why?
Prevalence
1
2017
2564
0.080
 Why?
Genetic Testing
2
2025
430
0.080
 Why?
Patient Discharge
1
2016
836
0.080
 Why?
Cholesterol
1
2011
412
0.080
 Why?
Triglycerides
1
2011
528
0.080
 Why?
Kidney Failure, Chronic
1
2015
546
0.080
 Why?
ATP-Binding Cassette Transporters
1
2010
133
0.080
 Why?
Leukocytes
2
2012
306
0.080
 Why?
Longitudinal Studies
1
2016
2720
0.080
 Why?
Lipoproteins
1
2010
172
0.080
 Why?
Risk Assessment
3
2020
3262
0.070
 Why?
Lung Diseases
1
2014
741
0.070
 Why?
Databases, Factual
3
2021
1269
0.070
 Why?
Incidence
2
2020
2641
0.070
 Why?
Weight Gain
2
2021
509
0.070
 Why?
Drug Delivery Systems
1
2010
333
0.070
 Why?
Indinavir
1
2006
7
0.070
 Why?
Pyrimidinones
1
2007
102
0.070
 Why?
Linear Models
2
2019
819
0.070
 Why?
Genetic Techniques
1
2006
63
0.070
 Why?
Reproducibility of Results
1
2014
3080
0.060
 Why?
Lamivudine
1
2006
61
0.060
 Why?
Factor X
1
2006
25
0.060
 Why?
Zidovudine
1
2006
78
0.060
 Why?
Prothrombin
1
2006
20
0.060
 Why?
Factor VII
1
2006
22
0.060
 Why?
Drug Utilization
1
2007
171
0.060
 Why?
Chemokines, CXC
1
2006
70
0.060
 Why?
Prognosis
2
2014
3774
0.060
 Why?
Oxidation-Reduction
1
2009
1028
0.060
 Why?
Base Sequence
2
2006
2147
0.060
 Why?
C-Reactive Protein
1
2008
400
0.060
 Why?
Biomarkers
3
2014
3968
0.060
 Why?
Regression Analysis
1
2008
997
0.060
 Why?
Delayed-Action Preparations
1
2006
172
0.060
 Why?
Pharmacovigilance
1
2024
21
0.060
 Why?
Health Care Surveys
1
2007
557
0.060
 Why?
Mathematical Computing
1
2004
11
0.060
 Why?
Gene Expression Regulation
1
2014
2542
0.060
 Why?
Gene Expression
1
2009
1465
0.060
 Why?
Risk Factors
3
2020
9786
0.050
 Why?
Drug Labeling
1
2004
41
0.050
 Why?
Infusions, Intravenous
1
2004
399
0.050
 Why?
Multidrug Resistance-Associated Proteins
3
2008
37
0.050
 Why?
Laboratories
1
2004
108
0.050
 Why?
Algorithms
3
2024
1616
0.050
 Why?
Kidney
2
2008
1386
0.050
 Why?
Reference Values
1
2004
794
0.050
 Why?
Drug Monitoring
1
2024
215
0.050
 Why?
Socioeconomic Factors
1
2007
1213
0.050
 Why?
Blood Coagulation
1
2024
239
0.050
 Why?
Linagliptin
1
2021
5
0.050
 Why?
Adamantane
1
2021
17
0.050
 Why?
Administrative Claims, Healthcare
1
2021
26
0.050
 Why?
Dipeptides
1
2021
47
0.050
 Why?
Electronic Prescribing
1
2021
3
0.050
 Why?
Electrocardiography
1
2004
611
0.040
 Why?
Uterine Hemorrhage
1
2021
33
0.040
 Why?
Protective Factors
1
2020
91
0.040
 Why?
Drug Tolerance
1
2000
90
0.040
 Why?
Costs and Cost Analysis
1
2020
201
0.040
 Why?
Animals
3
2008
35391
0.040
 Why?
Treatment Failure
1
2020
339
0.040
 Why?
Homozygote
2
2012
195
0.040
 Why?
Kaplan-Meier Estimate
1
2021
851
0.040
 Why?
Sex Factors
1
2024
1970
0.040
 Why?
Genomics
1
2024
718
0.040
 Why?
Antineoplastic Agents
1
2009
2046
0.040
 Why?
Attitude
1
2020
253
0.040
 Why?
Glipizide
1
2018
6
0.040
 Why?
Proportional Hazards Models
1
2021
1198
0.040
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.040
 Why?
Glyburide
1
2018
35
0.040
 Why?
Liver
1
2006
1842
0.040
 Why?
Dexamethasone
1
2000
350
0.030
 Why?
Social Class
1
2019
259
0.030
 Why?
Feasibility Studies
1
2021
869
0.030
 Why?
Self-Management
1
2019
163
0.030
 Why?
Self Report
1
2021
799
0.030
 Why?
Anesthetics
1
2017
66
0.030
 Why?
Membrane Transport Proteins
2
2008
149
0.030
 Why?
Peru
1
2016
53
0.030
 Why?
Tenofovir
2
2008
232
0.030
 Why?
Pharmaceutical Services
1
2016
81
0.030
 Why?
Cause of Death
1
2018
395
0.030
 Why?
Diabetic Angiopathies
1
2018
261
0.030
 Why?
Medicaid
1
2020
431
0.030
 Why?
Perioperative Care
1
2017
151
0.030
 Why?
South Africa
1
2016
192
0.030
 Why?
Indians, North American
1
2021
601
0.030
 Why?
Alternative Splicing
1
2017
217
0.030
 Why?
Preoperative Care
1
2017
338
0.030
 Why?
Hepatitis C, Chronic
1
2016
156
0.030
 Why?
HEK293 Cells
1
2017
698
0.030
 Why?
Rats, Sprague-Dawley
1
2000
2395
0.030
 Why?
Receptors, Steroid
1
2014
49
0.030
 Why?
Everolimus
1
2014
88
0.030
 Why?
Demography
1
2014
279
0.030
 Why?
Hypoglycemia
1
2018
427
0.030
 Why?
Vasodilator Agents
1
2014
326
0.020
 Why?
Age Factors
1
2019
3152
0.020
 Why?
Mental Disorders
1
2020
1034
0.020
 Why?
Heterozygote
1
2012
275
0.020
 Why?
Rats
1
2000
5483
0.020
 Why?
Genetic Loci
1
2012
275
0.020
 Why?
Neoplasms
1
2024
2455
0.020
 Why?
Critical Illness
1
2015
758
0.020
 Why?
Insulin
1
2019
2326
0.020
 Why?
Multivariate Analysis
1
2012
1499
0.020
 Why?
Genetic Predisposition to Disease
1
2017
2274
0.020
 Why?
Body Composition
1
2012
649
0.020
 Why?
Plasma
1
2009
205
0.020
 Why?
Lopinavir
1
2007
30
0.020
 Why?
PubMed
1
2006
10
0.020
 Why?
Ribosomal Proteins
1
2006
77
0.020
 Why?
Antiretroviral Therapy, Highly Active
1
2007
267
0.020
 Why?
Pharmacology
1
2005
9
0.010
 Why?
RNA, Messenger
1
2012
2708
0.010
 Why?
Molecular Sequence Data
1
2009
2835
0.010
 Why?
Likelihood Functions
1
2005
137
0.010
 Why?
Cardiotonic Agents
1
2005
126
0.010
 Why?
Mitochondrial Proteins
1
2006
247
0.010
 Why?
Genome
1
2006
278
0.010
 Why?
Chromosome Mapping
1
2005
505
0.010
 Why?
Hemorrhage
1
2008
680
0.010
 Why?
Drug Therapy, Combination
1
2006
1042
0.010
 Why?
Saccharomyces cerevisiae Proteins
1
2006
383
0.010
 Why?
Predictive Value of Tests
1
2008
1947
0.010
 Why?
Models, Genetic
1
2005
593
0.010
 Why?
Pilot Projects
1
2006
1592
0.010
 Why?
Child
1
2020
20884
0.010
 Why?
Computer Simulation
1
2005
939
0.010
 Why?
Case-Control Studies
1
2007
3378
0.010
 Why?
Inflammation
1
2006
2750
0.010
 Why?
Aquilante's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (357) concept(s)
_
Co-Authors Expand Description
See all (54) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)